<DOC>
	<DOCNO>NCT02734628</DOCNO>
	<brief_summary>The objective study investigate efficacy BepanthenÂ® wound heal ointment compare placebo superficial abrasive wound model . The primary objective re-epithelization Day 5 . The secondary objective re-epithelization Days 2 , 3 , 4 , 6 , 7 , 8 , 9 , 10 15 , assessment cosmetic outcome/acceptance Day 15 ( investigator ) Day 36 ( investigator subject ) , documentation analysis safety parameter .</brief_summary>
	<brief_title>Pilot Study Assess Number Patients Main Trial</brief_title>
	<detailed_description />
	<mesh_term>Pantothenic Acid</mesh_term>
	<criteria>Healthy Caucasian subject gender , 18 45 year age , Fitzpatrick skin type I IV Active skin disease , mole , tattoo , strong pigmentation test area scar test area would influence visual score History keloid hypertrophic scar History plaster sensitivity Intake drug interfere immune system within 30 day day 1 well study Concomitant therapy substance affect blood coagulation within 14 day prior start study well study Any condition treatment might influence study Change hormonal contraception within 3 month prior enrolment study Application topical treatment test area conduct study Intensive ultravioletlight exposure within two week begin well study Removal axillary lymph node Allergy ingredient test product Pregnancy lactation Any illness account subject participate study opinion investigator Psychiatric condition might limit participation trial and/or lead assumption ability completely understand consequence consent miss Any history drug addiction alcoholism past 3 year Infectious disease ( e.g . hepatitis AIDS )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>